https://www.thepeptidenewsroom.com/review-finds-glp-1-drugs-promising-in-hidradenitis-suppurativa-but-no-trials-exi/ The Peptide Newsroom en 2026-09-26 Review Finds GLP-1 Drugs Promising in Hidradenitis Suppurativa, But No Trials Exist Yet https://www.thepeptidenewsroom.com/nabela-noor-says-a-glp-1-was-one-tool-but-the-habits-did-the-work/ The Peptide Newsroom en 2026-09-26 Nabela Noor Says a GLP-1 Was One Tool, But the Habits Did the Work https://www.thepeptidenewsroom.com/case-report-pairs-semaglutide-with-implanted-pressure-sensor-in-an-82-year-old-h/ The Peptide Newsroom en 2026-09-26 Case Report Pairs Semaglutide With Implanted Pressure Sensor in an 82-Year-Old Heart Failure Patient https://www.thepeptidenewsroom.com/bpc-157-draws-scientific-interest-in-the-uk-but-mhra-lists-no-authorization/ The Peptide Newsroom en 2026-09-26 BPC-157 Draws Scientific Interest in the UK, But MHRA Lists No Authorization https://www.thepeptidenewsroom.com/what-the-research-says-about-tirzepatide-heart-protection-dental-records-and-the/ The Peptide Newsroom en 2026-09-25 What the Research Says About Tirzepatide: Heart Protection, Dental Records, and the Gaps Between Them https://www.thepeptidenewsroom.com/serena-williams-and-charles-barkley-endorse-ro-as-telehealth-glp-1-screening-dra/ The Peptide Newsroom en 2026-09-25 Serena Williams and Charles Barkley Endorse Ro as Telehealth GLP-1 Screening Draws Expert Scrutiny https://www.thepeptidenewsroom.com/endocrinologist-calls-peptide-injections-biochemically-interesting-but-says-huma/ The Peptide Newsroom en 2026-09-25 Endocrinologist Calls Peptide Injections Biochemically Interesting, But Says Human Evidence Is Missing https://www.thepeptidenewsroom.com/cowhide-collagen-peptides-paired-with-bitter-melon-lowered-blood-sugar-in-diabet/ The Peptide Newsroom en 2026-09-25 Cowhide Collagen Peptides Paired With Bitter Melon Lowered Blood Sugar in Diabetic Mice, Study Finds https://www.thepeptidenewsroom.com/byomas-21-99-peptide-serum-wins-a-rave-review-but-the-trial-numbers-lack-a-denom/ The Peptide Newsroom en 2026-09-25 Byoma's £21.99 Peptide Serum Wins a Rave Review, But the Trial Numbers Lack a Denominator